Johns Hopkins Medicine invites you to join the conversation with leading experts about current challenges in precision medicine.
Johns Hopkins inHealth Precision Medicine Symposium
Precision Medicine and the transformation of health care: advancing health using novel measurement, analysis, and communication.
May 30, 2019 in the Turner Conference Center
- Convene with thought leaders in precision medicine
- Discover opportunities for improving care through patient subgroups
- Examine how to use cutting edge technology to promote individualized care
- Explore exhibitor organizations that enable precision medicine functions
What do precision medicine, Johns Hopkins inHealth and Darwin have in common? If you’re interested, please plan to attend our first ever inHealth Precision Medicine Conference on Tuesday, March 27 from 8am to 1pm in Tilghman Auditorium. You’ll learn about the new analytics, big data, and measurement platforms we’re building to transform medicine, as well as some highly creative approaches your colleagues have taken to further define individual diseases and conditions to both improve care and minimize cost. Please RSVP by sending your name to JHontheRoad@jhmi.edu by Friday, March 23rd.
Hear from top scientists on how they recommend expanding and implementing the Blue Ribbon Panel’s road map for cancer research. They’ll discuss a report that will be published by the journal The Lancet Oncology and is co-edited by Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, and Chi Van Dang, M.D., Ph.D., scientific director at Ludwig Cancer Research and professor at The Wistar Institute. Learn what you need to know about investing in research, prevention and treatment of cancer, the second leading cause of death in the U.S. Reserve your attendance now by emailing JHontheRoad@jhmi.edu.
As the cost of health care in the United States continues to rise, of utmost concern are reports that medical bills are creating substantial hardships for patients. Health care debt is now the leading contributor to individual bankruptcy and home foreclosures. Both insured and uninsured patients are burdened by medical bills. And health care quality and safety are compromised as people avoid even the most basic and necessary care because of cost. Health care providers are in a unique position to lead the transition to value-based care. Medical providers and professional societies across the country are working to reduce use of unnecessary tests, procedures and treatments that increase patients’ financial burdens without adding value to their care.
One of the most recent examples of individualized or precision medicine is cancer immunotherapy. This approach of making cancer cells visible to the patient’s own immune system, allowing it to take action against cancer, has led to numerous success stories for those with various cancers. What do leaders predict for the future of immunotherapy? How are academia and drug companies working together to move this field forward? Learn more from a panel of health care industry leaders, including those from the Bloomberg~Kimmel Institute for Cancer Immunotherapy, patient advocacy groups and the pharmaceutical industry.